pilot study stanozolol advanced breast carcinoma Eighteen patients advanced metastatic carcinoma breast hormone therapy stanozolol pilot study efficacy toxicity population patients advanced breast cancer patients partial responses PR patients stable disease SD Toxicity androgen therapy Stanozolol large groups patients role management metastatic breast carcinoma 